ArticleNeuroendocrinology2020

Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.

Somer Matar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.